Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-499a-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 242, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
HNF4A hsa-miR-499a-5p low: 2 high: 0 1 2 1 -
Low-throughput experiments (0 positive, 2 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Maria Hatziapostolou et al. 2011 RP Liver HEP3B HEP3B N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
Maria Hatziapostolou et al. 2011 RP Liver HEPG2 HEPG2 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
FBXL3 hsa-miR-499a-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr13:77005773-77005797 Chimeric fragments POSITIVE DIRECT TarBase 8.0
RCN2 hsa-miR-499a-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:76949304-76949327 Chimeric fragments POSITIVE DIRECT TarBase 8.0
SH3RF1 hsa-miR-499a-5p low: 0 high: 4 1 1 1 0.630
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr4:169096214-169096239 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr4:169096214-169096239 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:169096214-169096239 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr4:169096214-169096239 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GXYLT1 hsa-miR-499a-5p low: 0 high: 3 2 4 1 0.554
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:42082065-42082083 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:42082065-42082083 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:42082065-42082083 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Hafner M. et al. 2010 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
GTF3C4 hsa-miR-499a-5p low: 0 high: 3 1 3 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr9:132689515-132689543 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:132689515-132689543 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:132689515-132689543 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MAP3K7 hsa-miR-499a-5p low: 0 high: 3 1 3 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr6:90515721-90515741 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:90515721-90515741 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:90515721-90515741 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ZNF711 hsa-miR-499a-5p low: 0 high: 3 1 1 1 0.802
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chrX:85272702-85272724 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chrX:85272702-85272724 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:85272702-85272724 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KLHL9 hsa-miR-499a-5p low: 0 high: 3 1 3 1 0.475
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr9:21334507-21334528 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:21334507-21334528 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:21334507-21334528 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HIST1H2BK hsa-miR-499a-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:27146396-27146421 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:27146396-27146421 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:27146396-27146421 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FECH hsa-miR-499a-5p low: 0 high: 2 1 2 1 0.453
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr18:57549781-57549809 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr18:57549781-57549809 PAR-CLIP POSITIVE DIRECT TarBase 7.0
XPO4 hsa-miR-499a-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr13:20862728-20862754 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr13:20779658-20779681 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ETS1 hsa-miR-499a-5p low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr11:128461753-128461781 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:128461753-128461781 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RRP1B hsa-miR-499a-5p low: 0 high: 2 2 2 2 0.813
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr21:43695735-43695749 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr21:43695273-43695294 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TM2D2 hsa-miR-499a-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:38988971-38988995 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:38988971-38988995 HITS-CLIP POSITIVE DIRECT TarBase 7.0
INSIG1 hsa-miR-499a-5p low: 0 high: 2 2 2 2 0.653
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:155309310-155309338 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr7:155309310-155309338 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARID2 hsa-miR-499a-5p low: 0 high: 2 1 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:45906222-45906243 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:45906222-45906243 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MYO1C hsa-miR-499a-5p low: 0 high: 2 1 2 1 0.685
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:1464543-1464562 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:1464543-1464562 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CUX1 hsa-miR-499a-5p low: 0 high: 2 2 2 2 0.910
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:102251198-102251216 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:102255466-102255484 HITS-CLIP POSITIVE DIRECT TarBase 7.0
XYLT2 hsa-miR-499a-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:50361093-50361113 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:50361093-50361113 HITS-CLIP POSITIVE DIRECT TarBase 7.0